INCISIVE Implementation Guide
0.1.1 - draft
INCISIVE Implementation Guide
0.1.1 - draft
INCISIVE Implementation Guide - Local Development build (v0.1.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://fhir.incisive-project.eu/ConceptMap/ProstateTumorProfileResultConceptMap | Version: 0.1.1 | |||
| Draft as of 2024-03-19 | Computable Name: ProstateTumorProfileResultConceptMap | |||
Tumor profile result model of Prostate cancer to the FHIR Profile map
It shows how the tumor profile result model of Prostate cancer is mapped into the FHIR Profile/structureDefinition
Mapping from Tumor profile result Prostate to Observation for Prostate cancer
DRAFT (not intended for production usage). Published on 2024-03-19 13:26:22+0100 by INCISIVE (INCISIVE: https://incisive-project.eu/, fhir@incisive-project.eu).
Tumor profile result model of Prostate cancer to the FHIR Profile map
Group 1Mapping from Tumor profile result Prostate to Observation for Prostate cancer
| Source Code | Relationship | Target Code |
| ProstateTumorProfileResultLogicalModel.tumorProfileResultID (An identifier for the tumor profile result) | is related to | Observation.id |
| ProstateTumorProfileResultLogicalModel.patientID (INCISIVE patient) | is equivalent to | Observation.subject.reference |
| ProstateTumorProfileResultLogicalModel.biopsyID (INCISIVE patient) | is related to | Observation.partOf.reference |
| ProstateTumorProfileResultLogicalModel.maxGleason (Gleason score (observable entity)) | is related to | Observation.component.valueInteger |
| ProstateTumorProfileResultLogicalModel.cribriformFeatures (Cribriform neoplasm pattern (finding)) | is related to | Observation.component.valueBoolean |
| ProstateTumorProfileResultLogicalModel.intraductal (Non-infiltrating intraductal carcinoma (morphologic abnormality)) | is related to | Observation.component.valueBoolean |
| ProstateTumorProfileResultLogicalModel.percentOfAffectedCoresInLeftLobe (% of affected cores in right lobe) | is related to | Observation.component.valueQuantity |
| ProstateTumorProfileResultLogicalModel.percentOfAffectedCoresRightLobe (% of affected cores in the left lobe) | is related to | Observation.component.valueQuantity |
| ProstateTumorProfileResultLogicalModel.isupGroup (Histologic grade of urothelial carcinoma by World Health Organization and International Society of Urological Pathology technique (observable entity)) | is related to | Observation.component.valueInteger |
| ProstateTumorProfileResultLogicalModel.extraprostaticExtension (American Joint Committee on Cancer pT3 (qualifier value)) | is related to | Observation.component.valueBoolean |
| ProstateTumorProfileResultLogicalModel.seminalVesicleInvasion (American Joint Committee on Cancer pT3b (qualifier value)) | is related to | Observation.component.valueBoolean |
| ProstateTumorProfileResultLogicalModel.gleasonTotalPR (Gleason score (observable entity)) | is related to | Observation.component.valueInteger |
| ProstateTumorProfileResultLogicalModel.pN (American Joint Committee on Cancer pathological T category allowable value (qualifier value)) | is related to | Observation.component.valueCodeableConcept |
| ProstateTumorProfileResultLogicalModel.pT (American Joint Committee on Cancer pathological N category allowable value (qualifier value)) | is related to | Observation.component.valueCodeableConcept |
INCISIVE has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952179. However, the content of this website reflects the opinion of its authors and does not in any way represent opinions of the European Union. European Commission is not responsible for any use that may be made of the information the website contains.
https://ec.europa.eu/digital-single-market/en/policies/ehealth